Literature DB >> 11062311

Antioxidant Activity of Secoisolariciresinol Diglucoside-derived Metabolites, Secoisolariciresinol, Enterodiol, and Enterolactone.

.   

Abstract

Secoisolariciresinol diglucoside (SDG), an antioxidant isolated from flaxseed, is metabolized to secoisolariciresinol (SECO), enterodiol (ED), and enterolactone (EL) in the body. The effectiveness of SDG in hypercholesterolemic atherosclerosis, diabetes, and endotoxic shock could be due to these metabolites. These metabolites may have antioxidant activity. However, the antioxidant activity of these metabolites is not known. The antioxidant activity of SECO, ED, and EL was investigated using chemiluminescence (CL) of zymosan-activated polymorphonuclear leukocytes (PMNLs) [PMNL-CL]. Other antioxidants (SDG and vitamin E) were also used for comparison. SDG, SECO, ED, EL, and vitamin E, each in the concentration of 0.5, 1.0, 2.5, 5.0 and 10.0 mg/ml, produced a concentration-dependent reduction in zymosan-activated PMNL-CL. SDG, SECO, ED, EL, and vitamin E, in the concentration of 2.5 mg/ml, produced a reduction of zymosan-activated PMNL-CL by 23.8%, 91.2%, 94.2%, 81.6% and 18.7%, respectively. Activated PMNLs produce reactive oxygen species and luminol-dependent CL reflects the amount of oxygen species generated from activated PMNLs. The reduction of PMNL-CL, therefore, reflects the antioxidant activity of the compounds studied. These results suggest that the metabolites of SDG have antioxidant activity. The antioxidant activity was highest with SECO and ED and lowest with vitamin E. The antioxidant potency of SECO, ED, EL, and SDG was 4.86, 5.02, 4.35, and 1.27 respectively, as compared to vitamin E. SECO, ED and EL are respectively 3.82, 3.95, and 3.43 more potent than SDG.

Entities:  

Year:  2000        PMID: 11062311     DOI: 10.1007/bf01623898

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  45 in total

1.  Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.

Authors:  Carol J Fabian; Bruce F Kimler; Carola M Zalles; Jennifer R Klemp; Brian K Petroff; Qamar J Khan; Priyanka Sharma; Kenneth D R Setchell; Xueheng Zhao; Teresa A Phillips; Trina Metheny; Jennifer R Hughes; Hung-Wen Yeh; Karen A Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-19

2.  Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans.

Authors:  Thomas Clavel; Gemma Henderson; Carl-Alfred Alpert; Catherine Philippe; Lionel Rigottier-Gois; Joël Doré; Michael Blaut
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

3.  Dietary flaxseed modulates the miRNA profile in irradiated and non-irradiated murine lungs: a novel mechanism of tissue radioprotection by flaxseed.

Authors:  Melpo Christofidou-Solomidou; Ralph Pietrofesa; Evguenia Arguiri; Melissa A McAlexander; Kenneth W Witwer
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

Review 4.  Flaxseed-a potential functional food source.

Authors:  Priyanka Kajla; Alka Sharma; Dev Raj Sood
Journal:  J Food Sci Technol       Date:  2014-02-28       Impact factor: 2.701

5.  Serum biochemical changes in rabbits on a regular diet with and without flax lignan complex following a high-cholesterol diet.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2008

Review 6.  Role of phytoestrogens in prevention and management of type 2 diabetes.

Authors:  Mohammad Talaei; An Pan
Journal:  World J Diabetes       Date:  2015-03-15

Review 7.  Flaxseed for hypertension: implications for blood pressure regulation.

Authors:  Stephanie P B Caligiuri; Andrea L Edel; Michel Aliani; Grant N Pierce
Journal:  Curr Hypertens Rep       Date:  2014-12       Impact factor: 5.369

8.  Dietary flaxseed prevents radiation-induced oxidative lung damage, inflammation and fibrosis in a mouse model of thoracic radiation injury.

Authors:  James C Lee; Ryan Krochak; Aaron Blouin; Stathis Kanterakis; Shampa Chatterjee; Evguenia Arguiri; Anil Vachani; Charalambos C Solomides; Keith A Cengel; Melpo Christofidou-Solomidou
Journal:  Cancer Biol Ther       Date:  2009-01-01       Impact factor: 4.742

9.  Discovery of a sesamin-metabolizing microorganism and a new enzyme.

Authors:  Takuto Kumano; Etsuko Fujiki; Yoshiteru Hashimoto; Michihiko Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-21       Impact factor: 11.205

10.  Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies.

Authors:  L S Velentzis; M M Cantwell; C Cardwell; M R Keshtgar; A J Leathem; J V Woodside
Journal:  Br J Cancer       Date:  2009-03-31       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.